Slone Infosystems IPO Hits 19x Subscription on Day One!

Slone Infosystems Limited IPO saw robust demand, and subscribed 19.07 times on Day 1, indicating high investor confidence and interest in the tech company's market debut.
Slone Infosystems IPO Hits 19x Subscription on Day One!

Slone Infosystems Limited IPO has been enthusiastically received, with the issue being subscribed 19.07 times on the first day, reflecting strong investor confidence and a high level of interest in the tech firm’s market debut.

Invest in Direct Mutual Funds IPOs Bonds and Equity at ZERO COST

How To Check Slone Infosystems Limited IPO Subscription Status? 

Steps to check the IPO subscription status on NSE

Following are the steps to check it through the NSE website

  • Visit NSE‘s official website.
  • Navigate to the ‘Market Data’ tab.
  • Choose ‘IPO’.
  • Select the Slone Infosystems Limited IPO to check its subscription status.
  • Opt for either NSE Bid details or Consolidated Bid details.
  • Explore the total number of bids received from various investors. 

Slone Infosystems Limited IPO Allotment Status

The allotment date for the Slone Infosystems Limited IPO is set for May 8, 2024, with shares priced at a range of₹79 per share and a face value of ₹10. The offering consists of lots of 1600 shares, with bids accepted for these lots or their multiples.

Slone Infosystems Limited IPO Listing Date 

Slone Infosystems Limited IPO is expected to be listed on the NSE SME on May 10, 2024.

Read More News
Q4 Results में धमाकेदार प्रदर्शन से Balkrishna Industries का शेयर 13% उछला, बना रिकॉर्ड

Q4 Results में धमाकेदार प्रदर्शन से Balkrishna Industries का शेयर 13% उछला, बना रिकॉर्ड!

प्रभावशाली Q4 परिणामों के बाद, Balkrishna Industries का शेयर मूल्य 5% ऊपरी सर्किट के साथ 52-सप्ताह के उच्चतम स्तर पर पहुंच गया। EBITDA में सालाना आधार पर ग्रोथ 42% है। BSE पर स्टॉक ₹2,798.95 पर खुला।

Zydus Lifesciences Q4 Result शेयर में 5% की छलांग, मुनाफा ₹1,182 करोड़

Zydus Lifesciences Q4 Result: शेयर में 5% की छलांग, मुनाफा ₹1,182 करोड़!

Q4FY24 के लिए लगभग 300% सालाना शुद्ध लाभ वृद्धि के साथ 1,182 करोड़ रुपये की रिपोर्ट के बाद Zydus Lifesciences के शेयर 1,104.45 रुपये के रिकॉर्ड उच्च स्तर पर पहुंच गए। मजबूत EBITDA वृद्धि के कारण स्टॉक सात महीनों में 89% बढ़ गया।

Enjoy Low Brokerage Trading Account In India

Save More Brokerage!!

We have Zero Brokerage on Equity, Mutual Funds & IPO